Primary Recipient

EMORY UNIVERSITY

Amount

$150,000.00

Award Date

9/10/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Efficacy and Mechanisms of GLN Dipeptide in the SICU (GLND trial): The purpose of this supplement is to accelerate the tempo of research in the current NIH/NIDDK-funded trial U01 DK069322 (the GLND study) by adding an additional study site at the Universi